News|Articles|November 18, 2026

From Awareness to Action: Pharmacists Advancing Antibiotic Stewardship

Listen
0:00 / 0:00

Key Takeaways

  • Antimicrobial resistance accounts for >2.8 million US infections and >35,000 deaths annually, rising to >3 million infections and 48,000 deaths when C difficile is included.
  • Outpatient settings comprise 85%–95% of human antibiotic use, with at least 28% of prescriptions unnecessary, underscoring stewardship focus on appropriateness beyond utilization reduction.
SHOW MORE

As antibiotic resistance keeps growing, Utah’s stewardship work shows how pharmacists can turn US Antibiotic Awareness Week into year-round action.

Antibiotics are among the most important therapeutic advances in modern medicine. They have transformed once fatal bacterial infections into treatable conditions and support surgery, organ transplantation, cancer chemotherapy, and the care of critically ill patients. Yet their effectiveness cannot be taken for granted. Antimicrobial resistance (AR) continues to threaten the ability to treat infections safely and effectively.

The CDC estimates that more than 2.8 million antimicrobial-resistant infections occur in the United States each year and more than 35,000 people die as a result of antibiotic resistance.

When Clostridioides difficile, which is associated with antibiotic exposure, is included, the annual burden exceeds 3 million infections and 48,000 deaths. CDC and collaborators have also estimated that treating infections caused by 6 antimicrobial-resistant pathogens frequently encountered in health care contributes more than $4.6 billion in annual health care costs.1,2

These numbers make clear that improving antibiotic use is not simply a prescribing issue; it is a patient-safety and public-health priority. US Antibiotic Awareness Week (USAAW) provides an annual opportunity for pharmacists, prescribers, nurses, dentists, public health professionals, patients, and other partners to reinforce the importance of appropriate antibiotic use. The greater challenge is turning that awareness into sustained action throughout the year.

Why Stewardship Matters

Antibiotics save lives when they are needed, but every exposure has potential consequences, including adverse drug events, C difficile infection, disruption of the microbiome, and selection pressure that contributes to resistance. CDC reports that 85% to 95% of human antibiotic use occurs in outpatient settings and that at least 28% of outpatient antibiotic prescriptions are unnecessary. There are additional opportunities to improve antibiotic selection, dose, and duration.3

Antibiotic stewardship is therefore not simply an effort to reduce antibiotic use. Its purpose is to improve how antibiotics are prescribed and used so that patients receive treatment when there is a clear health benefit and avoid unnecessary exposure when antibiotics are unlikely to help. CDC identifies improving antibiotic use as a key strategy to optimize patient safety and combat antimicrobial resistance.4

From Awareness to Measurement in Utah

At the Utah Department of Health and Human Services (DHHS), our antimicrobial stewardship work increasingly connects surveillance, research, education, and implementation. Our efforts span community pharmacies, nursing homes, hospitals, critical access hospitals, and outpatient care. The objective is to understand where and how antibiotics are being used, identify gaps in stewardship implementation, and translate those findings into practical interventions.

Research is an important part of that process because stewardship programs need local data. National recommendations establish the framework, but local assessments can identify the barriers, resources, and prescribing patterns that should shape interventions.

Community Pharmacists: An Underused Stewardship Resource

Community pharmacists are among the most accessible health care professionals and are often the final clinician a patient encounters before taking an antibiotic. Our study, “Understanding the Implementation of Antimicrobial Stewardship in Utah Community Pharmacies,” evaluated stewardship knowledge, activities, barriers, and facilitators among Utah community pharmacists.5

Among 110 respondents, 71.6% reported prior familiarity with antimicrobial stewardship. Only 47.7% consistently intervened when an antibiotic dose or frequency appeared inappropriate. Nearly 80% reported limited access to patient clinical or laboratory information, 53.4% identified the absence of standardized guidelines as a barrier, and 41.5% reported provider resistance to pharmacist-led antibiotic interventions.5

The study also pointed toward solutions. Better access to patient records was identified as a facilitator by 86.4% of respondents, while 75.2% supported better access to guidelines and 75.2% supported greater collaboration with prescribers.5

These findings suggest that expanding pharmacists’ access to clinical information, evidence-based tools, education, and collaborative relationships could strengthen outpatient stewardship.

Building Stewardship Capacity in Nursing Homes

Long-term care is another important stewardship priority. In “Implementing Antimicrobial Stewardship Core Elements in Utah Nursing Homes,” our team assessed implementation of CDC stewardship Core Elements among Utah nursing homes.6

Among 49 responding facilities, 96% reported leadership support, and at least 1 facility had a policy supporting antimicrobial stewardship. However, approximately one-third lacked infectious diseases expertise, only 24% had a hospital antimicrobial stewardship partner, and approximately one-third lacked antibiotic-prescribing protocols for common clinical situations. Twenty-two percent reported uncertainty regarding who was accountable for antimicrobial stewardship activities.6

These findings demonstrate why having a stewardship requirement alone is not sufficient. Facilities also need practical treatment tools, clinical expertise, clear accountability, antibiotic-use tracking, reporting mechanisms, and continuing education. Utah DHHS continues to build on this work through recurring point-prevalence surveys of antibiotic use in nursing homes, creating opportunities to monitor use over time and identify targets for intervention.

Using Medicaid and Claims Data to Understand Prescribing

Population-level data can provide another view of antibiotic use. In 2026, our team published “Outpatient Antibiotic Prescribing Among Utah Medicaid Recipients: A 4-Year Population-Based Analysis” in the American Journal of Infection Control. The study evaluated outpatient pharmacy claims from January 2019 through July 2023, including the period affected by the COVID-19 pandemic.7

This type of surveillance helps stewardship programs move beyond a single facility or health system. These efforts align with CDC’s approach to outpatient stewardship. CDC notes that outpatient pharmacy dispensing data can be used to track antibiotic use, while administrative claims data can help assess the appropriateness of antibiotics prescribed for specific diagnoses.3

The key question is not only how many antibiotics are prescribed, but also whether they were needed and, when indicated, whether the agent and duration were appropriate.

Antimicrobial Stewardship ECHO: Turning Evidence Into Education

Collecting data and publishing research are important, but the goal is to translate findings into better care. One way we are doing this is through the Utah Antimicrobial Stewardship ECHO series, developed in collaboration with the University of Utah.

The ECHO model creates an interactive learning community that connects clinicians and other health care professionals with subject-matter experts while allowing participants to discuss real-world stewardship challenges. Our programming has addressed stewardship in hospitals, critical access and rural facilities, urgent care, diagnostic stewardship, and other areas of antibiotic use.

About the Author

Tariq A. Mosleh, PharmD, PhD, is an antimicrobial stewardship pharmacist in the Healthcare-Associated Infections/Antimicrobial Resistance Program at the Utah Department of Health and Human Services. He is also an adjunct assistant professor in the School of Medicine at the University of Utah Salt Lake City, Utah.

The current focus is dental antimicrobial stewardship. We are incorporating dental stewardship education into the ECHO series and sharing practical stewardship resources with Utah dental professionals. This is particularly timely because CDC updated its Core Elements of Outpatient Antibiotic Stewardship in 2026, including setting-specific resources for dental care, telemedicine, hemodialysis, and other outpatient environments.8

ECHO can therefore serve as a bridge between evidence and implementation. Surveillance identifies where improvement may be needed; research helps characterize the problem; and education, collaboration, and implementation help turn those findings into practice.

Pharmacists as Stewardship Leaders

Pharmacists are uniquely positioned at the intersection of these activities. In hospitals, pharmacists can optimize antimicrobial selection and dosing, support prospective audit and feedback, facilitate intravenous-to-oral conversion, evaluate allergies and drug interactions, and help clinicians reassess therapy as diagnostic information becomes available.

In nursing homes, pharmacists can support facility stewardship programs and evaluate antibiotic selection and duration. In community settings, pharmacists can identify potentially inappropriate doses or durations, communicate with prescribers, counsel patients, and reinforce why antibiotics do not treat viral infections.

The pharmacist’s role can also extend beyond direct patient care. Pharmacists can analyze antibiotic-use data, conduct research, develop educational programs, support public health surveillance, and translate national recommendations into locally feasible interventions.

Make USAAW a Starting Point

USAAW is an important opportunity to remind clinicians and patients that antibiotics are a precious resource, but stewardship must continue throughout the year. A useful cycle is straightforward: measure antibiotic use, identify gaps, study the problem, share the findings, educate clinicians and patients, implement interventions, and measure again.

In Utah, community pharmacy research is helping define opportunities for pharmacist engagement. Nursing-home assessments identify both progress and persistent implementation gaps. Medicaid and claims analyses provide population-level insight into outpatient prescribing. ECHO provides a mechanism for translating these findings and national recommendations into education and practice.

The goal is not simply fewer antibiotics—its better antibiotic use. Patients with bacterial infections that require treatment should receive effective antibiotics promptly. When antibiotics are not indicated, avoiding unnecessary exposure protects the individual patient while helping preserve antimicrobial effectiveness for the broader community.

During USAAW, pharmacists have an opportunity to communicate that message. Throughout the rest of the year, we have an even greater opportunity to put it into practice.

References
1. Centers for Disease Control and Prevention. Antimicrobial Resistance Facts and Stats. Accessed September 30, 2026. https://www.cdc.gov/antimicrobial-resistance/data-research/facts-stats/
2. Centers for Disease Control and Prevention. CDC partners estimate healthcare cost of antimicrobial-resistant infections. Updated February 4, 2025. Accessed September 30, 2026. https://www.cdc.gov/antimicrobial-resistance/stories/partner-estimates.html
3. Centers for Disease Control and Prevention. Antibiotic Use in the United States. Updated September 15, 2025. Accessed September 30, 2026. https://www.cdc.gov/antibiotic-use/hcp/data-research/antibiotic-prescribing.html
4. Centers for Disease Control and Prevention. Antibiotic Use and Stewardship in the United States, 2025 Update: Progress and Opportunities. Updated February 9, 2026. Accessed September 30, 2026. https://www.cdc.gov/antibiotic-use/hcp/data-research/stewardship-report.html
5. Mosleh TA, Clements A, Beard D, et al. Understanding the implementation of antimicrobial stewardship in Utah community pharmacies. JAC Antimicrob Resist. 2025;7(5):dlaf155. doi:10.1093/jacamr/dlaf155
6. Mosleh TA, Clements A, Beard D, Weil A, Radloff C, Schenk C. Implementing antimicrobial stewardship core elements in Utah nursing homes. Am J Infect Control. 2025;53(9):938-942. doi:10.1016/j.ajic.2025.05.006
7. Mosleh TA, Weil A, Beard D, et al. Outpatient antibiotic prescribing among Utah Medicaid recipients: a 4-year population-based analysis. Am J Infect Control. 2026;54(8):873-877. doi:10.1016/j.ajic.2026.03.005
8. Centers for Disease Control and Prevention. Core Elements of Outpatient Antibiotic Stewardship. Updated August 3, 2026. Accessed September 30, 2026. cdc.gov/antibiotic-use/core-elements/outpatient.html

Related to this article